Valuation: Guilin Sanjin Pharmaceutical Co., Ltd.

Market Cap 7.09B 1.06B 954M 881M 799M 1.49B 101B 1.51B 10.57B 4.2B 52.95B 3.99B 3.91B 168B P/E 2024
17x
P/E 2025 19.1x
Enterprise Value 5.88B 882M 792M 731M 663M 1.24B 83.81B 1.25B 8.77B 3.48B 43.93B 3.31B 3.24B 139B EV / Sales 2024
3.55x
EV / Sales 2025 3.46x
Free-Float
22.45%
Yield 2024
3.98%
Yield 2025 3.55%
1 day-1.47%
1 week-0.90%
Current month-1.23%
1 month-0.25%
3 months-8.84%
6 months-13.54%
Current year-14.40%
1 week 11.82
Extreme 11.82
12.28
1 month 11.82
Extreme 11.82
12.55
Current year 11.82
Extreme 11.82
14.95
1 year 11.82
Extreme 11.82
15.75
3 years 11.28
Extreme 11.28
18.35
5 years 10.59
Extreme 10.59
21.67
10 years 10.59
Extreme 10.59
21.67
Manager TitleAgeSince
Chief Executive Officer 50 -
Director of Finance/CFO 49 27/12/2025
Corporate Officer/Principal 56 26/12/2022
Director TitleAgeSince
Chairman 50 14/01/2022
Director/Board Member 46 26/12/2019
Chairman 58 26/12/2022
Date Insider Type Main position Quantity % Market Cap. Importance
29/04/24 Buy

Chairman

148,300 0.0268%
29/09/20 Sell

Chairperson

89,100 0.0165%
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%-0.90%-19.69%-20.33% 1.08B
+0.22%-0.14%+55.12%+128.82% 1,140B
+0.91%+3.61%+41.21%+84.57% 641B
-0.12%-0.93%+25.59%+106.14% 507B
+0.63%+2.33%+49.21%+67.82% 383B
+0.86%-4.37%+61.16%+37.93% 347B
+1.02%+1.80%+24.84%+53.75% 293B
-0.25%+1.62%+2.20%+26.65% 266B
+0.75%+2.05%+53.85%+71.25% 240B
+0.25%+1.64%+32.05%+107.62% 197B
Average +0.28%+0.98%+32.55%+66.42% 401.49B
Weighted average by Cap. +0.44%+0.96%+42.19%+88.45%

Financials

2024 2025
Net sales 2.19B 329M 295M 273M 247M 462M 31.25B 468M 3.27B 1.3B 16.38B 1.23B 1.21B 51.94B 2.05B 307M 275M 254M 231M 431M 29.14B 436M 3.05B 1.21B 15.27B 1.15B 1.13B 48.43B
Net income 522M 78.21M 70.19M 64.81M 58.77M 110M 7.43B 111M 777M 309M 3.89B 294M 287M 12.35B 433M 64.95M 58.29M 53.82M 48.81M 91.22M 6.17B 92.34M 645M 256M 3.23B 244M 239M 10.25B
Net Debt -1.08B -162M -146M -134M -122M -228M -15.41B -231M -1.61B -640M -8.08B -609M -596M -25.62B -1.21B -181M -163M -150M -136M -254M -17.2B -257M -1.8B -714M -9.01B -680M -665M -28.59B
Projected Income Statement - Annual - Guilin Sanjin Pharmaceutical Co., Ltd.
Logo Guilin Sanjin Pharmaceutical Co., Ltd.
Guilin Sanjin Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, manufacturing and sales of Chinese patent medicines. The Company mainly operates in the two major areas of oral and throat health and urinary health, including the prevention, self-treatment and rehabilitation of common household diseases such as cardiovascular and cerebrovascular, nervous system, respiratory system and digestive system. The Company's main products include Sanjin Tablets, Guilin Xiguashuang, Xiguashuang Throat Tablets, Xiguashuang Qingyan Lozenges, Naomaitai Capsules, Xuanyunning Tablets/Granules, Gejie Dingchuan Capsules, Yuye Jiedu Granules.
Employees
2,556
Date Price Change Volume
27/10/26 CN¥12.07 -1.47% 1,133,400
26/10/26 CN¥12.25 +1.16% 1,361,502
23/10/26 CN¥12.11 +0.67% 1,694,000
22/10/26 CN¥12.03 -0.91% 1,329,300
21/10/26 CN¥12.14 -0.33% 957,100

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Guilin Sanjin Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002275 Stock